Loading stock data…
BlossomHill Therapeutics, Inc. (BLSM)
$22.93+0.92 (+4.18%)
After Hours$24.00+1.07 (+4.67%)· Last close Sep 8
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $0 | $0 |
| Gross Profit | — | — |
| Operating Income | -$22.11M↓ | -$11.45M |
| Net Income | -$21.01M↓ | -$10.48M |
Peer Comparison
JNJUNHPFE
Fundamentals
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$666.83M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
20.70%
Volume
Today's trading volume
229,155
